JACC-Heart Failure

Papers
(The H4-Index of JACC-Heart Failure is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Myeloperoxidase in Heart Failure With Preserved Ejection Fraction240
Reply175
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status175
Editorial Board161
Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function126
Developing a System for Best Performance for Cardiac Transplantation105
Tachycardia and Atrial Fibrillation-Related Cardiomyopathies102
Full issue PDF87
Geographic Variation in the Quality of Heart Failure Care Among U.S. Veterans79
Opportunities for Change in Home Health Care in Heart Failure76
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction72
Reply71
Predictors of Incident Heart Failure Diagnosis Setting70
Exercise Blood Pressure in Heart Failure With Preserved and Reduced Ejection Fraction68
Clinical Inertia Disturbs the Harmonious Treatment of Heart Failure66
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia61
Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype58
Revisiting ICD Therapy for Primary Prevention58
Examination of Initiation Patterns for Sacubitril/Valsartan Among Older Adults With HFrEF in the United States57
Wearable Remote Patient Monitoring Devices57
CHIEF Effects of Sodium Glucose Co-Transporter Inhibitors on Health-Related Quality of Life in Heart Failure57
Curing Ourselves of Toxic Positivity for Hospital-at-Home54
Long-Term Effects of Sotatercept on Right Ventricular Function54
Eating to Prevent Both Heart and Planetary Failure53
Associations Between Urinary Metal Levels and Incident Heart Failure52
Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure50
Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome50
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF49
Correction49
Early U.S. Heart Transplant Experience With Normothermic Regional Perfusion Following Donation After Circulatory Death48
Challenges Addressing Prognosis in Advanced Heart Failure47
Thank You for the Privilege46
The Urgent Need for More Cardiac Rehabilitation in the Aim to “Preserve” Patients With Heart Failure46
Reply45
Hospital at Home as a Novel Care Strategy for Worsening Heart Failure44
Clinical Utility of the H2FPEF Score in Patients With Early Atrial Fibrillation44
The Path Toward a More Equitable Transplant System42
GDF-15 in Cardiovascular Disease42
Inhibiting Both Neprilysin and Phosphodiesterase Type 942
Increasing the Utilization of Sac/Val in Elderly HFrEF Patients Eligible for ARNI Treatment41
0.026766061782837